Drug intelligence / Profile preview

JYNNEOS

Development stage
Approved
Lead developer
Bavarian Nordic
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

JYNNEOS is a live, non-replicating vaccine based on the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) strain. It is indicated for the prevention of smallpox and mpox (monkeypox) disease in adults 18 years of age and older who are determined to be at high risk for these infections. The vaccine elicits both humoral and cellular immune responses against orthopoxviruses by inducing vaccinia-neutralizing antibodies. Effectiveness was inferred from immunogenicity data compared to licensed smallpox vaccines and supported by animal challenge studies. JYNNEOS does not contain preservatives and is available in both liquid-frozen and freeze-dried formulations[1][2][3][6].

Brand names
JYNNEOSIMVAMUNEIMVANEX
Other names
Smallpox and Mpox vaccine, live, non-replicatingModified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine

Beyond the preview

Go deeper on JYNNEOS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JYNNEOS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call